$15.2M Valsartan, Losartan & Irbesartan Contamination Settlement, Are You Eligible? Claim Deadline is June 2, 2026
Three pharmaceutical manufacturers — Aurobindo, Hetero, and Vivimed — agreed to pay a combined $15.2 million to settle claims that their blood pressure medications were contaminated with cancer-causing substances. If you paid for irbesartan, valsartan, or losartan manufactured by these companies at any point since 2016, you may qualify for a cash payment. The claim…
